High-Quality Tirzepatide Weight Loss Injection Powder 20 mg/bottle Company, Product

Name: Tirzepatide for Injection Purity: 99% Appearance: White Lyophilized Powder Size: 20mg Water: 3.0% Solubility: Conforms HPLC ldentification: Conforms Bacterial Endotoxins: Less than 5 EU/mg MS ldentification: 4810.6 Benefits:  Weight Loss  

Product Description

Tirzepatide Weight Loss Injection Powder 20mg/bottle is usually used for research purposes or to prepare solutions for clinical development. Here is key product details, usage instructions, and safety information:

Product Information

  • Product Name Tirzepatide Weight Loss Injection Powder
  • Dosage Specification 20mg/bottle
  • Purity Grade ≥99% (Research Grade)
  • Form Lyophilized Powder
Primary Application & Storage
  • Main Use Weight management & Type 2 diabetes research
  • Storage Temperature Refrigerate (2°C ~ 8°C)
  • Environment Avoid light and high temperature
  • Usage Window Use as soon as possible after preparation

Instructions for Use

  • 1 Dissolution: Use sterile water (Bacteriostatic Water, BW) or 0.9% sodium chloride solution for dissolution.
  • 2 Concentration: Prepare the appropriate dose as needed based on specific research parameters.
  • 3 Injection Method: Subcutaneous injection (SC), recommended once a week.
Important Precautions
  • For research purposes only, not for direct human treatment, and must be used under the guidance of a professional physician.
  • The prepared solution must be used within 24-48 hours and long-term storage must be avoided.
  • Always ensure strict aseptic operation during handling to prevent contamination.

Frequently Asked Questions (FAQ)

Q1: What is the primary purpose of Tirzepatide Weight Loss Injection Powder 20mg?

It is primarily intended for research purposes, including weight management and type 2 diabetes research, or for preparing solutions during clinical development.

Q2: How should the product be stored to maintain its quality?

The product should be kept refrigerated at temperatures between 2°C and 8°C. It must be protected from light and high temperatures, and used promptly once prepared.

Q3: Which solutions can be used to dissolve the lyophilized powder?

The powder can be dissolved using sterile water (Bacteriostatic Water, BW) or a 0.9% sodium chloride solution.

Q4: What is the recommended administration route and frequency?

The solution is administered via subcutaneous injection (SC), and the recommended application frequency is once a week.

Q5: How long can the solution be stored after reconstitution?

Once prepared, the solution must be used within 24 to 48 hours. Long-term storage of reconstituted solution should be avoided.

Q6: Is this product suitable for direct human medical treatment?

No, it is for research purposes only and not for direct human treatment. It must always be handled under professional medical or clinical guidance with aseptic techniques.

Related Products